Nanjing King-Friend Biochemical Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nanjing King-Friend Biochemical Pharmaceutical Co Ltd with three other
companies in this sector in China:
Beijing SL Pharmaceutical Co Ltd
sales of 1.24 billion Chinese Renmimbi [US$197.28 million]
of which 98%
was Pharmaceuticals Industry),
Staidson (Beijing) Biopharmaceuticals Co Ltd
(1.39 billion Chinese Renmimbi [US$220.44 million]
of which 100%
was Pharmaceutical manufacturing), and
Chongqing Zhifei Biological Products Co Ltd
(1.34 billion Chinese Renmimbi [US$213.24 million]
of which 96%
was Biological Product).